Bank of Montreal’s Clearside Biomedical CLSD Stock Holding History

Bank of Montreal’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2	Closed	–	–	4746
2019 Q2	$0	Buy	+2	New	+$36	﹤0.01%	4873
2019 Q1	–	Sell	-26	Closed	–	–	4369
2018 Q4	$0	Buy	26 +13	+100%	+$610	﹤0.01%	4680
2018 Q3	$1K	Hold	13	–	–	﹤0.01%	4502
2018 Q2	$2K	Sell	13 -654	-98%	-$110K	﹤0.01%	4330
2018 Q1	$107K	Buy	+667	New	+$81.3K	﹤0.01%	2933

Other funds holding CLSD

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Bank of Montreal's CLSD Position: Q3 2019 in Review

Bank of Montreal sold out of Clearside Biomedical (CLSD) in Q3 2019, closing a stake of 2 shares.

Bank of Montreal first reported a position in CLSD in Q1 2018 and held it in 5 quarters. The position peaked at $107K in Q1 2018. 34 funds tracked by Wall St. Rank hold CLSD as of Q3 2019.

Bank of Montreal reported no remaining Clearside Biomedical position as of Q3 2019 after selling out during the quarter.
Bank of Montreal sold 2 Clearside Biomedical shares in Q3 2019.
Bank of Montreal first reported a position in Clearside Biomedical in Q1 2018 and held it in 5 quarters.
Bank of Montreal's Clearside Biomedical position peaked at $107K in Q1 2018.
34 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2019.

Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.